Not sure what to write? Check out your company's website.Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers and immunological conditions by inhibiting the proteasome and thereby disrupting protein turnover in cells. In addition to its lead product candidate, carfilzomib (PR-171), which is delivered intravenously and is currently in multiple clinical trials to evaluate its safety and efficacy in multiple types of cancer, Proteolix is developing next generation proteasome inhibitors, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor, to expand the therapeutic potential of this new target class. Proteolix is headquartered in South San Francisco.
Company Details
- Founded
- -
- Address
- 333 Allerton Ave, Ssf,ca 94080,united States
- Phone
- 650-266-2600
- in****@****lix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- proteolix.com
- Keywords
- Cancer Drugs.
- HQ
- SSF, Ca
Proteolix Questions
Proteolix's helpline number is 650-266-2600
Proteolix's website is proteolix.com
Proteolix's LinkedIn profile is https://www.linkedin.com/company/proteolix
Proteolix's industry is
Biotechnology Research
Proteolix's top competitors are
Howard Hughes Medical Institute (Hhmi),
Halda Therapeutics,
Forma Therapeutics,
Cleave Therapeutics, Inc.,
Genentech,
Orbital Therapeutics,
Arvinas,
Modifi Bio,
Proteologix Inc,
Biotechnology Innovation Organization.
Proteolix's support email address is info@proteolix.com
Proteolix's categories are Biotechnology Research
Proteolix's founding year is 2003
